Search

Günther Oettinger calls for ‘flexible’ approach on post-Brexit science deal, while standing firm on freedom of movement. And, he acknowledges, losing the UK’s scientific heft could damage the EU’s global standing in R&D

A special report by Science|Business journalists explains the challenges of coordinating the growing research and innovation effort in Brussels

Romania’s Dan Nica will handle regulation and rules of participation for the next research programme, while German MEP Christian Ehler will take on specific programme

Current EU health chief plays down fear from civil society groups that next Commission will drop EU health role

Patients are getting more access and control over their health records, but for now there are no plans to systematically collect data on outcomes

There’s huge variation around Europe in healthcare. Experts convened by Science|Business over the past two years offer explanations – and solutions

Science and policy groups will draft rules of participation in June, and Austrian presidency will sign off on a governance structure in November

KU Leuven has officially launched the Leuven Brain Institute (LBI). The institute is a new meeting place for brain researchers from all over the university. The goal is to boost knowledge about the nervous system through new collaborations.

New features in cohesion funding include incentives for cross-border investment and a dramatically scaled down rulebook

Former Italian prime minister Mario Monti tapped to find successor to current president, Jean-Pierre Bourguignon

As Austria’s EU Presidency approaches, health official Clemens Auer says it’s time to stop the pilots and let digital health fly

Sam Gyimah is pushing for favourable terms for UK membership in Horizon Europe. “You don’t want to put a cap on excellence,” he says

European Commission proposes a change to intellectual property rules to let generic drugmakers enter non-EU markets faster. Patent holders are not happy